Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

被引:105
作者
Locke, Jeffrey B. [1 ]
Hilgers, Mark [1 ]
Shaw, Karen Joy [1 ]
机构
[1] Trius Therapeut Inc, San Diego, CA 92121 USA
关键词
IN-VITRO ACTIVITY; PEPTIDYL-TRANSFERASE CENTER; LINEZOLID RESISTANCE; CROSS-RESISTANCE; PRODRUG TR-701; AUREUS; RNA; TIAMULIN; SUSCEPTIBILITY; CHLORAMPHENICOL;
D O I
10.1128/AAC.01032-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Following recent reports of ribosomal protein L3 mutations in laboratory-derived linezolid-resistant (LZDr) Staphylococcus aureus, we investigated whether similar mutations were present in LZDr staphylococci of clinical origin. Sequence analysis of a variety of LZDr isolates revealed two L3 mutations, Delta Ser145 (S. aureus NRS127) and Ala157Arg (Staphylococcus epidermidis 1653059), both occurring proximal to the oxazolidinone binding site in the peptidyl transferase center. The oxazolidinone torezolid maintained a >= 8-fold potency advantage over linezolid for both strains.
引用
收藏
页码:5275 / 5278
页数:4
相关论文
共 32 条
[1]  
BOCK A, 1982, J BACTERIOL, V151, P1253
[2]   Resistance to the peptidyl transferase inhibitor tiamulin caused by mutation of ribosomal protein L3 [J].
Bosling, J ;
Poulsen, SM ;
Vester, B ;
Long, KS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2892-2896
[3]   In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid:: relationship with susceptibility to penicillin G or macrolides [J].
Carsenti-Dellamonica, H ;
Galimand, M ;
Vandenbos, F ;
Pradier, C ;
Roger, PM ;
Dunais, B ;
Sabah, M ;
Mancini, G ;
Dellamonica, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) :633-642
[4]  
Clinical Laboratory Standards Institute, 2006, M7A7 CLSI
[5]   Structural basis for cross-resistance to ribosomal PTC antibiotics [J].
Davidovich, Chen ;
Bashan, Anat ;
Yonath, Ada .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) :20665-20670
[6]  
DeLano WL., 2002, PYMOL MOL GRAPHICS S
[7]   Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance [J].
Feng, Jie ;
Lupien, Andreanne ;
Gingras, Helene ;
Wasserscheid, Jessica ;
Dewar, Ken ;
Legare, Danielle ;
Ouellette, Marc .
GENOME RESEARCH, 2009, 19 (07) :1214-1223
[8]   Stepwise exposure of Staphylococcus aureus to pleuromutilins is associated with stepwise acquisition of mutations in rplC and minimally affects susceptibility to retapamulin [J].
Gentry, Daniel R. ;
Rittenhouse, Stephen F. ;
McCloskey, Lynn ;
Holmes, David J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) :2048-2052
[9]   In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants [J].
Hillemann, Doris ;
Ruesch-Gerdes, Sabine ;
Richter, Elvira .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :800-801
[10]   LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers) [J].
Jones, Ronald N. ;
Fritsche, Thomas R. ;
Sader, Helio S. ;
Ross, James E. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 59 (03) :309-317